Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 8/20 | 0.43 |
| ▸ | KDM5A | P29375 | 6/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | KDM4A | O75164 | 2/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.40 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14064830 | 0.93 | GGPS1 (0.47) | KDM4CKDM5AKDM4APHF8GGPS1 | |
| SCHEMBL7081091 | 0.85 | — | — | |
| SCHEMBL21938818 | 0.84 | CES2 (0.44) | GGPS1FDPSAGTR1OPRM1PDE3A | |
| SCHEMBL8415760 | 0.84 | KDM4C (0.42) | KDM4CKDM5ACA12CA1CA9 | |
| SCHEMBL14216628 | 0.81 | PAOX (0.34) | — | |
| SCHEMBL868479 | 0.81 | KDM4C (0.52) | KDM4CKDM5ACA12CA1CA9 | |
| SCHEMBL6445581 | 0.81 | KDM4C (0.43) | KDM4CKDM5ACA12CA1CA9 | |
| Acetic Acid SCHEMBL3416510 | 0.80 | KDM4C (0.55) | KDM4CKDM5ACA12CA1CA9 | |
| SCHEMBL10655777 | 0.80 | S1PR2 (0.42) | KDM4CKDM5ACA12CA1CA9 | |
| SCHEMBL8337243 | 0.79 | ALDH1A1 (0.54) | KDM4CKDM5ACA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3055313-B1 | CYCLIC THIENOURACIL CARBOXAMIDE AND ITS USE | Bayer Pharma AG (DE) | 2017-11-22 | — | — | EP | disclosed |
| US-20140256638-A1 | PEPTOID NEUTRALIZING AGENTS | UNIV CALIFORNIA (US) | 2014-09-11 | — | — | US | disclosed |
| US-20140256639-A1 | PEPTOID NEUTRALIZING AGENTS | UNIV CALIFORNIA (US) | 2014-09-11 | — | — | US | disclosed |
| US-20030118520-A1 | Cleaning composition for dental prostheses | CLARIANT GMBH (DE) | 2003-06-26 | — | — | US | disclosed |
| US-20020122775-A1 | Cleaning compostion for dental prostheses | CLARIANT GMBH | 2002-09-05 | — | — | US | disclosed |
| EP-1203576-A1 | Denture cleaning composition | Clariant GmbH (DE) | 2002-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118520-A1 | Cleaning composition for dental prostheses | NOXO1, AOX1, AOC1 | KDM4C 960/4885KDM5A 726/4885CA12 962/4885 |
| US-20140256638-A1 | PEPTOID NEUTRALIZING AGENTS | SERPINC1, ANTXR2, VIP | KDM4C 4440/4885KDM5A 4415/4885CA12 227/4885 |
| US-20020122775-A1 | Cleaning compostion for dental prostheses | NOXO1, AOX1, AOC1 | KDM4C 1212/4885KDM5A 849/4885CA12 821/4885 |
| US-20140256639-A1 | PEPTOID NEUTRALIZING AGENTS | SERPINC1, ANTXR2, VIP | KDM4C 4440/4885KDM5A 4415/4885CA12 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.